FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560612100> ?p ?o ?g. }

• W2560612100 endingPage "1085" @default.
• W2560612100 startingPage "1085" @default.
• W2560612100 abstract "Abstract Abstract 1085 Poster Board I-107 Background Benign types of bone marrow failure such as aplastic anemia (AA) and refractory anemia (RA) of MDS defined by the FAB classification occasionally present various chromosomal abnormalities, although the clinical significance of each abnormality is unclear. Small populations of CD55-CD59- granulocytes and erythrocytes are detected in approximately 50% of patients with AA and 15% of patients with RA (Br J Haematol 2009). Analyzing the relationship between the presence of a certain chromosomal abnormality and PNH-type cells may be useful in deducing the clinical significance of the karyotype abnormalities because such PNH-type cells represent a good marker for the benign bone marrow failure with immune pathophysiology. Patients and Methods From 1995 through 2009, peripheral blood from 2487 patients with AA or RA was examined for the presence of PNH-type cells using high sensitivity flow cytometry. Chromosome data on bone marrow cells were available in 1513 patients. The proportion of patients possessing PNH-type cells was determined in a subset of AA or RA defined by various chromosomal abnormalities. The sorted PNH-type granulocytes from some patients with chromosomal abnormalities were subjected to FISH analysis to determine the origin of the cells. Results Chromosomal abnormalities were detected in 16% of the patient population, 11% (59/546) in patients possessing PNH-type cells (PNH+ patients) and 19% (186/967) in patients without increased PNH-type cells (PNH- patients). The most frequent chromosomal abnormalities were trisomy 8 (+8) (3.6%), deletion of 20q (del(20q)) (2.4%), deletion of 13q (del(13q)) (1.0%), monosomy 7 (-7) (0.5%), deletion of 5q (del(5q)) (0.3%) in order of descending prevalence. The proportion of PNH+ patients in each patient group defined by chromosomal abnormality was 24%, 14%, 73%, 0% and 0% respectively. The proportion of PNH+ patients in patients with normal karyotype was 35%. Notably, patients with del(13q) showed a remarkably high prevalence of PNH-type cells (73%), even significantly higher than the prevalence of the patients without chromosomal abnormalities (P<0.01). The high prevalence of PNH-type cells was compatible with the previous finding that patients with del(13q) were likely to respond to immunosuppressive therapy (Br J Haematol, 2002). On the other hand, the proportion of PNH+ in patients with +8 and del(20q) or -7 was significantly lower than that of patients without chromosomal abnormalities (P<0.05, P<0.01 and P<0.05). In particular, none of the patients with -7 and del(5q) showed PNH-type cells, indicating the pathophysiology of the bone marrow failure with these chromosomal abnormalities to be non-immune mediated. FISH analysis of sorted PNH-type granulocytes showed the normal karyotype, indicating the PNH-type cells were derived from normal karyotype cells. Conclusions The presence of del(13q) in AA or RA represents benign bone marrow failure associated with a good response to immunosuppressive therapy, while the presence of -7 and del(5q) is thus considered to be related to a non-immune pathophysiology. AA and RA with +8 or del(20q) comprise a small subset of immune-mediated bone marrow failure. Disclosures No relevant conflicts of interest to declare." @default.
• W2560612100 created "2016-12-16" @default.
• W2560612100 creator A5008529645 @default.
• W2560612100 creator A5028349481 @default.
• W2560612100 creator A5043874175 @default.
• W2560612100 creator A5044588922 @default.
• W2560612100 creator A5054578501 @default.
• W2560612100 creator A5058177413 @default.
• W2560612100 date "2009-11-20" @default.
• W2560612100 modified "2023-10-17" @default.
• W2560612100 title "Clinical Significance of Chromosomal Abnormalities in Patients with Aplastic Anemia and Refractory Anemia Deduced From the Prevalence of PNH-Type Cells." @default.
• W2560612100 doi "https://doi.org/10.1182/blood.v114.22.1085.1085" @default.
• W2560612100 hasPublicationYear "2009" @default.
• W2560612100 type Work @default.
• W2560612100 sameAs 2560612100 @default.
• W2560612100 citedByCount "1" @default.
• W2560612100 countsByYear W25606121002021 @default.
• W2560612100 crossrefType "journal-article" @default.
• W2560612100 hasAuthorship W2560612100A5008529645 @default.
• W2560612100 hasAuthorship W2560612100A5028349481 @default.
• W2560612100 hasAuthorship W2560612100A5043874175 @default.
• W2560612100 hasAuthorship W2560612100A5044588922 @default.
• W2560612100 hasAuthorship W2560612100A5054578501 @default.
• W2560612100 hasAuthorship W2560612100A5058177413 @default.
• W2560612100 hasConcept C104317684 @default.
• W2560612100 hasConcept C109159458 @default.
• W2560612100 hasConcept C126322002 @default.
• W2560612100 hasConcept C142724271 @default.
• W2560612100 hasConcept C174475383 @default.
• W2560612100 hasConcept C203014093 @default.
• W2560612100 hasConcept C2778248108 @default.
• W2560612100 hasConcept C2780007613 @default.
• W2560612100 hasConcept C2780189214 @default.
• W2560612100 hasConcept C2780365373 @default.
• W2560612100 hasConcept C2780525284 @default.
• W2560612100 hasConcept C2781440808 @default.
• W2560612100 hasConcept C28328180 @default.
• W2560612100 hasConcept C2908647359 @default.
• W2560612100 hasConcept C30481170 @default.
• W2560612100 hasConcept C53226629 @default.
• W2560612100 hasConcept C54355233 @default.
• W2560612100 hasConcept C63363279 @default.
• W2560612100 hasConcept C71924100 @default.
• W2560612100 hasConcept C86803240 @default.
• W2560612100 hasConcept C90924648 @default.
• W2560612100 hasConcept C99454951 @default.
• W2560612100 hasConceptScore W2560612100C104317684 @default.
• W2560612100 hasConceptScore W2560612100C109159458 @default.
• W2560612100 hasConceptScore W2560612100C126322002 @default.
• W2560612100 hasConceptScore W2560612100C142724271 @default.
• W2560612100 hasConceptScore W2560612100C174475383 @default.
• W2560612100 hasConceptScore W2560612100C203014093 @default.
• W2560612100 hasConceptScore W2560612100C2778248108 @default.
• W2560612100 hasConceptScore W2560612100C2780007613 @default.
• W2560612100 hasConceptScore W2560612100C2780189214 @default.
• W2560612100 hasConceptScore W2560612100C2780365373 @default.
• W2560612100 hasConceptScore W2560612100C2780525284 @default.
• W2560612100 hasConceptScore W2560612100C2781440808 @default.
• W2560612100 hasConceptScore W2560612100C28328180 @default.
• W2560612100 hasConceptScore W2560612100C2908647359 @default.
• W2560612100 hasConceptScore W2560612100C30481170 @default.
• W2560612100 hasConceptScore W2560612100C53226629 @default.
• W2560612100 hasConceptScore W2560612100C54355233 @default.
• W2560612100 hasConceptScore W2560612100C63363279 @default.
• W2560612100 hasConceptScore W2560612100C71924100 @default.
• W2560612100 hasConceptScore W2560612100C86803240 @default.
• W2560612100 hasConceptScore W2560612100C90924648 @default.
• W2560612100 hasConceptScore W2560612100C99454951 @default.
• W2560612100 hasIssue "22" @default.
• W2560612100 hasLocation W25606121001 @default.
• W2560612100 hasOpenAccess W2560612100 @default.
• W2560612100 hasPrimaryLocation W25606121001 @default.
• W2560612100 hasRelatedWork W1965001236 @default.
• W2560612100 hasRelatedWork W1983264920 @default.
• W2560612100 hasRelatedWork W2106234158 @default.
• W2560612100 hasRelatedWork W2125837235 @default.
• W2560612100 hasRelatedWork W2519770732 @default.
• W2560612100 hasRelatedWork W2573487694 @default.
• W2560612100 hasRelatedWork W2594770798 @default.
• W2560612100 hasRelatedWork W2880625729 @default.
• W2560612100 hasRelatedWork W2987756716 @default.
• W2560612100 hasRelatedWork W3023386604 @default.
• W2560612100 hasVolume "114" @default.
• W2560612100 isParatext "false" @default.
• W2560612100 isRetracted "false" @default.
• W2560612100 magId "2560612100" @default.
• W2560612100 workType "article" @default.